These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32547113)

  • 1. High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant
    Bai XR; Jiang DC; Yan SY
    Infect Drug Resist; 2020; 13():1447-1454. PubMed ID: 32547113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant
    He H; Zheng Y; Sun B; Tang X; Wang R; Tong Z
    J Thorac Dis; 2016 Oct; 8(10):2784-2792. PubMed ID: 27867554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens.
    Chen Z; Shi X
    Medicine (Baltimore); 2018 Sep; 97(38):e12467. PubMed ID: 30235740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.
    De Pascale G; Montini L; Pennisi M; Bernini V; Maviglia R; Bello G; Spanu T; Tumbarello M; Antonelli M
    Crit Care; 2014 May; 18(3):R90. PubMed ID: 24887101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
    Amat T; Gutiérrez-Pizarraya A; Machuca I; Gracia-Ahufinger I; Pérez-Nadales E; Torre-Giménez Á; Garnacho-Montero J; Cisneros JM; Torre-Cisneros J
    Clin Microbiol Infect; 2018 Jun; 24(6):630-634. PubMed ID: 28970161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
    Jean SS; Hsieh TC; Lee WS; Hsueh PR; Hsu CW; Lam C
    Medicine (Baltimore); 2018 Sep; 97(39):e12278. PubMed ID: 30278498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant
    Chang K; Wang H; Zhao J; Yang X; Wu B; Sun W; Huang M; Cheng Z; Chen H; Song Y; Chen P; Chen X; Gan X; Ma W; Xing L; Wang Y; Gu X; Zou X; Cao B
    Front Med (Lausanne); 2022; 9():772372. PubMed ID: 35755062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis.
    Xia G; Jiang R
    Medicine (Baltimore); 2020 Mar; 99(10):e19466. PubMed ID: 32150105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y; Jin L; Liu N; Luo X; Dong D; Tang J; Wang Y; You Y; Liu Y; Chen M; Yu Z; Hao Y; Gu Q
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection.
    Shin JA; Chang YS; Kim HJ; Kim SK; Chang J; Ahn CM; Byun MK
    Yonsei Med J; 2012 Sep; 53(5):974-84. PubMed ID: 22869481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy.
    Guner R; Hasanoglu I; Keske S; Kalem AK; Tasyaran MA
    Infection; 2011 Dec; 39(6):515-8. PubMed ID: 21789524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units.
    Bai XR; Wang ZZ; Li WC; Wang YG; Lou R; Qu X; Fan L; Zhang W; Wu YC; Yan SY; Zhang L
    BMC Infect Dis; 2023 Nov; 23(1):830. PubMed ID: 38012576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study.
    Assimakopoulos SF; Karamouzos V; Lefkaditi A; Sklavou C; Kolonitsiou F; Christofidou M; Fligou F; Gogos C; Marangos M
    Infez Med; 2019 Mar; 27(1):11-16. PubMed ID: 30882373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
    Cheng A; Chuang YC; Sun HY; Sheng WH; Yang CJ; Liao CH; Hsueh PR; Yang JL; Shen NJ; Wang JT; Hung CC; Chen YC; Chang SC
    Crit Care Med; 2015 Jun; 43(6):1194-204. PubMed ID: 25793437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study.
    Geng TT; Xu X; Huang M
    Medicine (Baltimore); 2018 Feb; 97(8):e9961. PubMed ID: 29465589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
    Metan G; Alp E; Yildiz O; Percin D; Aygen B; Sumerkan B
    J Chemother; 2010 Apr; 22(2):110-4. PubMed ID: 20435570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.